GLARGINE INSULIN

Course overview

INSULIN GLARGINE IS A SYNTHETIC VERSION OF HUMAN INSULIN THAT IS FDA APPROVED TO TREAT ADULTS AND CHILDREN WITH TYPE 1 DIABETES AND ADULTS WITH TYPE 2 DIABETES TO IMPROVE AND MAINTAIN GLYCEMIC CONTROL. INSULIN GLARGINE IS A LONG-ACTING INSULIN INJECTED ONCE DAILY AND PROVIDED A BASAL INSULIN LEVEL THROUGHOUT THE DAY. REGIMENS OFTEN COMBINE IT WITH RAPID-ACTING INSULIN TO OBTAIN OPTIMAL GLYCEMIC CONTROL. THE INSULIN SHOULD NOT BE USED TO TREAT DIABETIC KETOACIDOSIS, AS SHORT-ACTING INSULIN IS PREFERRED. THIS ACTIVITY WILL COVER THE INDICATIONS, MECHANISM OF ACTION, ADVERSE EFFECTS, CONTRAINDICATIONS, MONITORING, AND TOXICITY OF INSULIN GLARGINE PERTINENT FOR HEALTHCARE PROFESSIONALS.